We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 15, 2020

Durvalumab Therapy Following Chemoradiation vs Chemoradiation Alone in Patients With Stage III NSCLC

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Durvalumab Therapy Following Chemoradiation Compared With a Historical Cohort Treated With Chemoradiation Alone in Patients With Stage III Non-Small Cell Lung Cancer: A Real-World Multicentre Study
Eur. J. Cancer 2021 Jan 01;142(xx)83-91, A Desilets, F Blanc-Durand, S Lau, T Hakozaki, R Kitadai, J Malo, W Belkaid, C Richard, M Messaoudene, L Cvetkovic, S Kazandjian, M Tehfe, M Florescu, K Jao, N Daaboul, S Owen, B Shieh, J Agulnik, V Cohen, C Charbonneau, N Marcoux, N Blais, NB Leighl, PA Bradbury, G Liu, FA Shepherd, H Bahig, B Routy, A Sacher, A Elkrief

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading